Lifestyle Modification Program for Cardiovascular Risk Patients in Indonesia

Dewi Prabawati; Josephine Lorica

doi:10.3889/oamjms.2022.10970

Authors

Dewi Prabawati Department of Nursing, Sint Carolus School of Health Sciences, Jakarta, Indonesia https://orcid.org/0000-0003-0981-6973
Josephine Lorica Department of Nursing, St. Paul University Philippines, Cagayan, Philippines https://orcid.org/0000-0001-6660-6011

DOI:

https://doi.org/10.3889/oamjms.2022.10970

Keywords:

Cardiovascular disease, Healthy behavior, Hypertension, Lifestyle

Abstract

Purpose: Unhealthy lifestyle leads to an increased risk of contracting cardiovascular disease (CVD). This study aimed to determine the effectiveness of the LIFESTYLE modification program developed by the researcher. The program was designed in response to the needs of Indonesian patients. LIFESTYLE is an acronym for L-ose weight, I-dentify your risk, F-ood choice, E-xercise frequently, S-top smoking and alcohol, T-hink positive, Y-es to a healthy lifestyle, L-et’s control regularly, and E-veryone is supporting you.

Method: This study employed the quasi-experimental design, specifically pretest-posttest method along with time series. Fifty-eight (58) participants were purposively chosen and given a 12-week LIFESTYLE modification program in a community health center called Puskesmas in Indonesia. CVD risk and physiological parameters such as blood pressure, waist circumference, total blood cholesterol, and body mass index (BMI) were observed before, during, and after the intervention. CVD risk was estimated using Framingham 10-year CVD risk score of non-laboratory-based test.

Results: The mean for CVD risk and physiological parameters decreased after the participants underwent the LIFESTYLE modification program. The analysis of variance (ANOVA) revealed that there was a significant difference in the participants’ systolic blood pressure and total cholesterol (p<.001) before, during, and after the intervention.

Conclusion: The 12-week LIFESTYLE modification program is effective in increasing knowledge of cardiovascular risk and observing a healthy lifestyle. Also, this program facilitates early identification of risks for CVD and improves selected physiological parameters.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. New Initiative Launched to Tackle Cardiovascular Disease, the World’s Number One Killer Global Hearts. Geneva, Switzerland: World Health Organization; 2016. Available from: https://www.who.int/cardiovascular_diseases/en [Last accessed on 2016 Aug 12].

D’agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation. 2008;117(6):743-53. https://doi.org/10.1161/CIRCULATIONAHA.107.699579 PMid:18212285 DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.699579

Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in Southeast Asian and African regions: Need for effective strategies for prevention and control in primary health care settings. Int J Hypertens. 2013;2013:409083. https://doi.org/10.1155/2013/409083 PMid:23573413 DOI: https://doi.org/10.1155/2013/409083

National Institute for Health Research and Development. Riset Kesehatan Dasar (National Health Survey). Indonesia: Ministry of Health Republic of Indonesia; 2013.

Riley L, Cowan M. World Health Organization Noncommunicable Diseases Country Profiles. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2014.

Appel LJ. Lifestyle modification as a means to prevent and treat high blood pressure. J Am Soc Nephrol. 2003;14(suppl 2):S99- 102. https://doi.org/10.1097/01.ASN.0000070141.69483.5A PMid:12819311 DOI: https://doi.org/10.1097/01.ASN.0000070141.69483.5A

Green BB, Anderson ML, Cook AJ, Catz S, Fishman PA, McClure JB, et al. Using body mass index data in the electronic health record to calculate cardiovascular risk. Am J Prev Med. 2012;42(4):342-7. https://doi.org/10.1016/j.amepre.2011.12.009 PMid:22424246 DOI: https://doi.org/10.1016/j.amepre.2011.12.009

Bell K, Twiggs J, Olin BR, Date IR. Hypertension: The silent killer: Updated JNC-8 guideline recommendations. Alabama Pharm Assoc. 2015;8(3):1-8.

World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Sydney: Health Communications Australia; 2000.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Executive summary: Heart disease and stroke statistics-2015 update: A report from the American heart association. Circulation. 2015;131(4):434-41. https://doi.org/10.1161/CIR.0000000000000157 DOI: https://doi.org/10.1161/CIR.0000000000000157

Lewis SL, Bucher L, Heitkemper MM, Harding MM, Kwong J, Roberts D. Medical-Surgical Nursing: Assessment and Management of Clinical Problems, Single Volume. Amsterdam: Elsevier Health Sciences; 2016.

Mendis S, Mohan V. Non-laboratory-based prediction of cardiovascular risk. Lancet. 2008;371(9616):878-9. https://doi.org/10.1016/S0140-6736(08)60392-X DOI: https://doi.org/10.1016/S0140-6736(08)60392-X

Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Miller NH, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2960-84. https://doi.org/10.1016/j.jacc.2013.11.003 PMid:24239922 DOI: https://doi.org/10.1161/01.cir.0000437740.48606.d1

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. Guidelines: editor’s choice: 2016 European guidelines on cardiovascular disease prevention in clinical practice: The sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention and rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. https://doi.org/10.1093/eurheartj/ehw10 PMid:27222591 DOI: https://doi.org/10.1093/eurheartj/ehw106

Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: The NHANES I follow-up study cohort. Lancet. 2008;371(9616):15-21. https://doi.org/10.1016/S0140-6736(08)60418-3 DOI: https://doi.org/10.1016/S0140-6736(08)60418-3

Gaziano TA, Pandya A, Steyn K, Levitt N, Mollentze W, Joubert G, et al. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations. BMC Med. 2013;11(1):170. https://doi.org/10.1186/1741-7015-11-170 PMid:23880010 DOI: https://doi.org/10.1186/1741-7015-11-170

Siren R, Eriksson JG, Peltonen M, Vanhanen H. Impact of health counselling on cardiovascular disease risk in middle aged men: Influence of socioeconomic status. PLoS One. 2014;9(2):e88959. https://doi.org/10.1371/journal.pone.0088959 PMid:24551198 DOI: https://doi.org/10.1371/journal.pone.0088959

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 2003;289(19):2560-72. https://doi.org/10.1001/jama.289.19.2560 PMid:12748199 DOI: https://doi.org/10.1001/jama.289.19.2560

Hatter-Fisher DY, Harper W, Schaffner B. Promoting hypertension risk reduction: Outcomes of an academic-urban community project collaboration. Negro Educ Rev. 2015;66(1-4):69-87.

Basile JN. Systolic blood pressure: It is time to focus on systolic hypertension-especially in older people. BMJ. 2002;325(7370):917-8. https://doi.org/10.1136/bmj.325.7370.917 PMid:12399325 DOI: https://doi.org/10.1136/bmj.325.7370.917

Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation. 2005;113(6):898-918. https://doi.org/10.1161/CIRCULATIONAHA.106.171016 PMid:16380542 DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.171016

World Health Organization. Waist Circumference and Waist-hip Ratio: Report of a WHO Expert Consultation; 2008 December 8-11. Geneva, Switzerland: WHO Library Cataloguing-in- Publication Data; 2011.

Stuart-Shor EM, Berra KA, Kamau MW, Kumanyika SK. Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups. Circulation. 2012;125(1):171-84. https://doi.org/10.1161/CIRCULATIONAHA.110.968495 PMid:22215892 DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.968495

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report. Circulation. 2002;106(25):3143-421. PMid:12485966 DOI: https://doi.org/10.1161/circ.106.25.3143